Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Keryx Biopharmaceuticals Inc. (KERX)

-NCM
15.05 Down 0.30(1.95%) Jul 31, 3:59PM EDT
|After Hours : 15.05 0.00 (0.00%) Jul 31, 5:04PM EDT
Prev Close:15.35
Open:15.20
Bid:15.04 x 300
Ask:15.68 x 10000
1y Target Est:24.00
Beta:4.23
Next Earnings Date:N/A
Day's Range:15.00 - 15.37
52wk Range:8.29 - 17.46
Volume:1,065,864
Avg Vol (3m):1,616,400
Market Cap:1.38B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXDown 1.95%1.38B
BAXDown 1.84%40.53B
SHPGDown 1.89%48.18B

Key Statistics

Forward P/E (1 yr):75.25
P/S (ttm):140.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Jun-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback